Sherif R. Z. Abdel-Misih, MD
Dr. Sherif R.Z. Abdel-Misih is a surgical oncologist at Stony Brook Medicine and an Associate Professor of Surgery and Director of the General Surgery Residency Program at the Renaissance School of Medicine at Stony Brook University in Stony Brook, New York. He specializes in treating tumors of the upper gastrointestinal tract.
Education and Career
Dr. Abdel-Misih earned his medical degree from Jefferson Medical College at Thomas Jefferson University in Philadelphia, Pennsylvania. He completed a General Surgery internship and residency at the Cleveland Clinic.
This was followed by fellowship training in Surgical Oncology at Ohio State University and Arthur G. James Cancer Hospital, where he remained as a physician, Associate Professor of Surgery in the department of Surgical Oncology, and Associate Program Director of the General Surgery Residency Program before taking on his role at Stony Brook Medicine.[1]
Dr. Abdel-Misih is currently a clinical professor of surgery at Renaissance School of Medicine. He is also the director of the general surgery residency.
Dr. Abdel-Misih specializes in surgical oncology with a focus on gastrointestinal cancers and other cancer tumor types, including peritoneal mesothelioma.
He has extensive surgical oncology training in the use of advanced techniques, including the novel procedure that combines cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). This procedure with HIPEC has been shown to significantly extend patient survival.
Dr. Abdel-Misih believes that the foundation of good treatment involves multi-disciplinary treatment strategies that include chemotherapy and radiation, as well as surgery.[1]
Dr. Abdel-Misih forges strong relationships with his patients to better understand their unique personal backgrounds while providing the comprehensive care that each one needs.
Professional Memberships and Activities
In addition to being a Fellow of the American College of Surgeons (FACS), Dr. Abdel-Misih is a member of several professional medical organizations, including:[2]
- American Hepato-Pancreato-Biliary Association
- American College of Surgeons
- American College of Surgeons, Ohio Chapter
- Association for Academic Surgery
- American Society of Peritoneal Surface Malignancies
- Society of American Gastrointestinal and Endoscopic Surgeons
- Columbus Surgical Society
- Society for Surgery of the Alimentary Tract
- Society of Surgical Oncology
- Zollinger Surgical Society
He is also on the editorial board of the World Journal of Surgical Oncology and a reviewer for the Journal of Gastrointestinal Surgery.[2]
Research
Dr. Abel-Misih’s scientific endeavors have been directed at clinical and translational research related to gastrointestinal malignancies, as well as didactic and skills-based scientific inquiry into surgical education and training.
Dr. Abel-Misih’s publications include:[2]
- Kimbrough C, Beal E, Abdel-Misih S, Pawlik T, Cloyd J. Survival Outcomes Among Patients with Gastric Adenocarcinoma who Received Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery. JAMA Surgery. 2019 Jun 12. PMID: 31188418
- Paredes A, Guzman Pruneda F, Abdel-Misih S, Hays J, Dillhoff M, Pawlik T, Cloyd J. Perioperative Morbidity of Gastrectomy during CRS-HIPEC: An ACS-NSQUIP Analysis. Journal of Surgical Research. 2019 Apr 17; 241:31-39. PMID: 31004870
- Lyell N, Kitano M, Smith B, Gleisner A, Backes F, Cheng G, McCarter M, Abdel-Misih S, Jones E. The Effect of Preoperative Nutritional Status on Postoperative Complications and Overall Survival in Patients Undergoing Pelvic Exenteration: A Multi-disciplinary, Multi-Institutional Cohort Study. Am J Surg. 2019 Apr 4. PMID: 30982571
- Woelfel I, Strosberg D, Abdel-Misih S, Harzman A. Growth in Monthly Case Volume in the First Year of Post-Graduate Surgical Training. Am Surg. 2019 Jan 1; 85(1). PMID: 30764914
- Xourafas D, Pawlik T, Ejaz A, Dillhoff M, Abdel-Misih S, Tsung A, Cloyd J. Impact of Concomitant Ablation on the Perioperative Outcomes of Patients with Colorectal Liver Metastases Undergoing Hepatectomy: A Propensity Score Matched Nationwide Analysis. HPB. 2019 Feb 2. [Epub ahead of print]. PMID: 30718184
- Paredes A, Abdel-Misih S, Schmidt C, Dillhoff M, Pawlik T, Cloyd J. Predictors of Readmission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Surgical Research. 2019 Feb; 234: 103 – 109. PMID: 30527460
- Chakedis J, Beal E, Sun S, Galo J, Chafitz A, Dillhoff M, Reardon J, Dillhoff M, Pawlik T, Abdel-Misih S, Bloomston M, Schmidt C. Implementation and Early Outcomes for a Surgeon-Directed Hepatic Arterial Infusion Pump Program for Colorectal Liver Metastases. Journal of Surgical Oncology. 2018 Dec; 118 (7): 1065 – 1073. PMID: 30376157
- Abdel-Misih S, Musindi W, Strafford K, Walker C, Verbeck-Osterhour N, Tartaglia K, Harman A. Early Experience with an Integrated Surgical and Obstetrics/Gynecology Clerkship: We Do Get Along. Am Journal of Surgery. 2018 Nov; 216(5):1016-1021. PMID: 29471965
- Burkhart J, Owen D, Shah MH, Abdel-Misih S, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW, Samorodnitsky E. Smith A, Konda B. Targeting BRAF Mutations in High-Grade Neuroendocrine Carcinoma of the Colon. Journal of the National Comprehensive Cancer Network. 2018 Sep; 16(9): 1035-1040. PMID: 30181415
